420 related articles for article (PubMed ID: 31919938)
1. Hypertrophic cardiomyopathy: the future of treatment.
Tuohy CV; Kaul S; Song HK; Nazer B; Heitner SB
Eur J Heart Fail; 2020 Feb; 22(2):228-240. PubMed ID: 31919938
[TBL] [Abstract][Full Text] [Related]
2. Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.
Philipson DJ; DePasquale EC; Yang EH; Baas AS
Heart Fail Rev; 2017 Nov; 22(6):879-888. PubMed ID: 28856513
[TBL] [Abstract][Full Text] [Related]
3. Multi-modality management of hypertrophic cardiomyopathy.
Rao SJ; Iqbal SB; Kanwal AS; Aronow WS; Naidu SS
Hosp Pract (1995); 2023 Feb; 51(1):2-11. PubMed ID: 36598161
[TBL] [Abstract][Full Text] [Related]
4. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
Sawan MA; Prabakaran S; D'Souza M; Behbahani-Nejad O; Gold ME; Williams BR; Bilen O
Clin Cardiol; 2024 Jan; 47(1):e24207. PubMed ID: 38269637
[TBL] [Abstract][Full Text] [Related]
6. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Sorajja P; Pedersen WA; Bae R; Lesser JR; Jay D; Lin D; Harris K; Maron BJ
J Am Coll Cardiol; 2016 Jun; 67(24):2811-8. PubMed ID: 27311518
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease.
Gilmanov DSh; Bevilacqua S; Solinas M; Ferrarini M; Kallushi E; Santarelli P; Farneti PA; Glauber M
Innovations (Phila); 2015; 10(2):106-13. PubMed ID: 25803770
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive trans-mitral septal myectomy for diffuse-type hypertrophic obstructive cardiomyopathy.
Sakaguchi T; Totsugawa T; Tamura K; Hiraoka A; Chikazawa G; Yoshitaka H
Gen Thorac Cardiovasc Surg; 2018 Jun; 66(6):321-326. PubMed ID: 29549506
[TBL] [Abstract][Full Text] [Related]
9. Robotic trans-mitral septal myectomy and papillary muscle reorientation for HOCM combined with or without mitral valve repair: Technical aspects - How we do it.
C J AK; Marc Gillinov A; Smedira NG; Hodges K; Burns DJP; Wierup P
J Card Surg; 2020 Nov; 35(11):3120-3124. PubMed ID: 32740992
[TBL] [Abstract][Full Text] [Related]
10. Obstructive hypertrophic cardiomyopathy: a review of new therapies.
Mehra N; Ali AH; Desai MY
Future Cardiol; 2023 Oct; 19(13):661-670. PubMed ID: 37933625
[TBL] [Abstract][Full Text] [Related]
11. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
[TBL] [Abstract][Full Text] [Related]
12. [Transmitral Septal Myectomy and Mitral Valve Plasty for Hypertrophic Obstructive Cardiomyopathy Combined with Organic Mitral Regurgitation;Report of a Case].
Matsuno Y; Fujita A; Kurazumi H; Ikenaga S
Kyobu Geka; 2020 Dec; 73(13):1101-1104. PubMed ID: 33271581
[TBL] [Abstract][Full Text] [Related]
13. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults.
Altarabsheh SE; Dearani JA; Burkhart HM; Schaff HV; Deo SV; Eidem BW; Ommen SR; Li Z; Ackerman MJ
Ann Thorac Surg; 2013 Feb; 95(2):663-9; discussion 669. PubMed ID: 23040828
[TBL] [Abstract][Full Text] [Related]
14. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
15. Unmet needs and future directions in hypertrophic cardiomyopathy.
Kaur S; Desai M
Prog Cardiovasc Dis; 2023; 80():1-7. PubMed ID: 37562518
[TBL] [Abstract][Full Text] [Related]
16. Resection, Plication, Release--the RPR procedure for obstructive hypertrophic cardiomyopathy.
Swistel DG; Balaram SK
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():31-6. PubMed ID: 17162267
[TBL] [Abstract][Full Text] [Related]
17. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae.
Minakata K; Dearani JA; Nishimura RA; Maron BJ; Danielson GK
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):481-9. PubMed ID: 14762358
[TBL] [Abstract][Full Text] [Related]
18. [Septal myectomy for obstructive hypertrophic cardiomyopathy: the gold standard].
Dearani JA; Schaff HV; Ommen SR
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):307-11. PubMed ID: 19791464
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.
Pelliccia F; Alfieri O; Calabrò P; Cecchi F; Ferrazzi P; Gragnano F; Kaski JP; Limongelli G; Maron M; Rapezzi C; Seggewiss H; Yacoub MH; Olivotto I
Int J Cardiol; 2020 Apr; 304():86-92. PubMed ID: 31983465
[TBL] [Abstract][Full Text] [Related]
20. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction.
Klues HG; Roberts WC; Maron BJ
Circulation; 1991 Sep; 84(3):1188-97. PubMed ID: 1884449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
